AfricaRegulatory
African Pharmaceutical Regulatory Intelligence
LAMIVUDINE USP
3 registrations across 3 African markets— 1 active
Markets with LAMIVUDINE USP
Recent registrations
| Brand / Product | Market | Holder | Status | Expires |
|---|---|---|---|---|
| Lamivudine 150 tablets Film Coated Tablets | 🇿🇲Zambia | MICRO LABS LTD | active | Apr 2031 |
| LAMIVUDINE AND ZIDOVUDINE TABLETS FOR ORAL SUSPENSION 30MG/60MG TABLETS/ 1 X 60 | 🇳🇬Nigeria | PHILLIPS PHARM (NIG.) LTD 122-133 | expired | Nov 2021 |
| LAMIVUDINE 300MG TABLETS TABLETS | 🇲🇼Malawi | — | expired | Jun 2018 |
LAMIVUDINE USP in Africa — Regulatory Overview
LAMIVUDINE USP is registered across 3 African markets with 3 total product registrations on file. Data is sourced directly from official national drug regulatory authorities including Malawi, Nigeria, Zambia. AfricaRegulatory refreshes this data daily from official government sources.
Of the 3 registrations, 1 (33%) are currently active. Regulatory affairs teams use AfricaRegulatory to track registration expiry dates, identify market incumbents, and monitor approval status across African markets without manual monitoring of each national regulator.